medsci-skills 4.1.0

package/skills/write-paper/references/journal_profiles/Journal_of_Stroke.md

@@ -0,0 +1,176 @@
+# Journal Profile: Journal of Stroke (J Stroke)
+
+## Basic Information
+
+- **Publisher:** Korean Stroke Society
+- **Society:** Korean Stroke Society
+- **Frequency:** 3 issues/year (January 31, May 31, September 30)
+- **Scope:** Cerebrovascular disease — ischemic stroke, hemorrhagic stroke, TIA, stroke prevention, acute treatment, neurorehabilitation, stroke systems of care
+- **Open Access:** Full OA (CC BY-NC 4.0); no article processing charge
+- **Language:** American English
+- **Editorial Office:** Asan Medical Center, Ulsan University College of Medicine (Seoul)
+
+---
+
+## Scope — Covered Topics
+
+- Acute ischemic stroke (IV thrombolysis, endovascular therapy, imaging selection)
+- Intracerebral hemorrhage and subarachnoid hemorrhage
+- Transient ischemic attack and minor stroke
+- Secondary stroke prevention (antithrombotics, risk factor management)
+- Cerebral small vessel disease and vascular cognitive impairment
+- Cerebrovascular imaging (CT/CTA/CTP, MRI/MRA, DSA)
+- Stroke epidemiology, registries, and outcomes research
+- Neurorehabilitation and recovery
+- Stroke clinical guidelines (regional and international)
+
+---
+
+## Manuscript Types and Word Limits
+
+| Type | Body Word Limit | Abstract | Figures/Tables | References |
+|------|----------------|----------|----------------|------------|
+| Special Review | ~8,000 words | 250 (unstructured) | 8 | unlimited |
+| Review | ~6,000 words | 250 (unstructured) | 6 | unlimited |
+| Original Article | 5,500 words | 250 (structured) | 6 | unlimited |
+| Guideline | variable (invited) | 250 | variable | variable |
+| Special Report | variable | 250 | variable | variable |
+| Editorial | ~1,500 words | None | 2 | ≤20 |
+| Letter to the Editor | 1,000 words | None | 2 | ≤10 |
+
+*Verify exact current limits on the author guidelines page before submission.*
+
+---
+
+## Abstract Requirements
+
+**Structured abstract, 250 words for Original Articles:**
+
+```
+Background and Purpose: [Clinical question; rationale]
+Methods: [Study design, population, interventions/exposures, outcomes, statistical approach]
+Results: [Key numerical results with effect sizes and 95% CI]
+Conclusions: [Main conclusion; clinical implication]
+```
+
+Unstructured 250-word abstract for Reviews and Special Reviews.
+
+---
+
+## Domain-Specific Outcome Measures
+
+### For Acute Stroke Studies
+
+- **Functional outcome at 90 days:** mRS (modified Rankin Scale); good outcome commonly defined as mRS 0–2
+- **Recanalization:** mTICI (modified Treatment in Cerebral Infarction) for endovascular studies; TIMI for older IV thrombolysis studies
+- **Symptomatic intracranial hemorrhage (sICH):** report definition used (ECASS II, ECASS III, SITS-MOST, NINDS, or Heidelberg)
+- **Early neurological improvement/deterioration:** NIHSS change (typically at 24 hours or discharge)
+- **Mortality at 90 days**
+
+### For Prevention / Epidemiology Studies
+
+- **Recurrent stroke (ischemic / hemorrhagic / any):** state the composite definition explicitly
+- **MACE (major adverse cardiovascular events):** define components
+- **Time-to-event outcomes:** Kaplan-Meier curves + Cox proportional hazards (test PH assumption)
+
+### For Imaging Studies
+
+- **Diagnostic accuracy:** sensitivity, specificity, AUC with 95% CI
+- **Inter-rater agreement:** Cohen's kappa or ICC depending on outcome type
+- **Report reference standard explicitly** (follow-up imaging, clinical adjudication, or autopsy)
+
+---
+
+## Required Sections
+
+1. **Introduction** — Clinical background; knowledge gap; specific aim
+2. **Methods**
+   - Ethics: IRB approval + informed consent statement (or exemption rationale for retrospective studies)
+   - Study design, setting, and participant selection
+   - Exposures and outcomes with explicit definitions
+   - Statistical analysis
+   - Reporting guideline citation (STROBE, CONSORT, PRISMA, STARD, TRIPOD)
+3. **Results**
+   - Participant flow / baseline characteristics
+   - Primary and secondary outcome results with effect sizes and 95% CI
+   - Subgroup and sensitivity analyses
+4. **Discussion**
+5. **Conclusion**
+
+---
+
+## Reference Style
+
+- **Vancouver numbered system**
+- Superscript reference numbers in the text
+- List first 3 authors followed by "et al." when there are more than 6 authors (verify current rule on author page)
+- Journal abbreviations per Index Medicus / NLM style
+
+---
+
+## Statistical Reporting Expectations
+
+- Report effect sizes (HR, OR, RR, absolute risk difference) with 95% CI — not p-values alone
+- State statistical software (version and package) used
+- For time-to-event analysis: Kaplan-Meier with log-rank test, Cox regression with PH assumption check
+- For diagnostic accuracy: AUC with 95% CI (DeLong method), sensitivity/specificity with Clopper-Pearson CI
+- Missing data: describe amount and handling (complete-case, multiple imputation, IPW)
+
+---
+
+## Figures
+
+- High-resolution TIFF, EPS, or PDF
+- Black-and-white for line art; RGB color accepted
+- Label panels with capital letters (A, B, C, ...)
+- Include scale bars for radiographs/histology
+- Figure legends separate from figures in the manuscript file
+
+---
+
+## Common Rejection Reasons
+
+1. **Scope mismatch** — non-cerebrovascular work, or work where the stroke component is incidental
+2. **Under-powered single-center retrospective series** without external validation or adequate sample-size justification
+3. **Weak comparison group** — historical controls without contemporaneous matched comparator
+4. **Missing reporting-guideline checklist** (STROBE/STARD/CONSORT/PRISMA as applicable)
+5. **Outcome definition vagueness** — mRS cutoff, recanalization success, sICH definition must be pre-specified and cited
+6. **Insufficient attention to prior regional literature** — Journal of Stroke expects engagement with Asia-Pacific stroke data where relevant
+
+---
+
+## Author Guidelines URL
+
+https://j-stroke.org/authors/authors.php
+
+---
+
+## AI Writing Disclosure Policy
+
+The author guidelines (last revised 2024-01-31) do not include an explicit generative-AI section. In the absence of a journal-specific policy, default to ICMJE and WAME recommendations:
+
+1. **AI cannot be an author** (ICMJE) — AI tools cannot take responsibility for the work.
+2. **Disclose substantive AI use** in the Methods (if involved in data generation, analysis, or writing of specific text) and/or Acknowledgments.
+3. **Do not use AI-generated references** without verification — the corresponding author remains responsible for citation accuracy.
+4. **Grammar / spell-check tools** do not require disclosure.
+5. **Image manipulation by generative AI is prohibited** for scientific figures.
+
+Authors should check the author guidelines page at submission time in case the policy has been updated.
+
+---
+
+## Positioning
+
+Journal of Stroke is appropriate when:
+- The study primarily concerns cerebrovascular disease (ischemic stroke, ICH, SAH, TIA, cSVD)
+- Open-access publication with no APC is a priority (full OA, CC BY-NC 4.0)
+- The target audience includes the Asia-Pacific stroke community
+- Clinical practice guidelines or special reports with regional relevance
+
+Journal of Stroke is less appropriate for: pure basic-science vascular biology (consider ATVB), purely interventional neuroradiology device papers (consider JNIS or INSI), or work with no cerebrovascular endpoint.
+
+---
+
+## Verification note
+
+Profile built 2026-04-19 from the journal's author guidelines PDF (https://j-stroke.org/authors/authors.php). Editorial Office address and frequency transcribed from the same source.

package/skills/write-paper/references/journal_profiles/KJR.md

@@ -0,0 +1,185 @@
+# Journal Profile: Korean Journal of Radiology (KJR)
+
+## Basic Information
+
+- **Publisher:** Korean Society of Radiology
+- **ISSN:** 1229-6929 (Print) / 2005-8330 (Electronic)
+- **Scope:** All subspecialties of diagnostic and interventional radiology; medical imaging AI. Excludes radiation oncology, dentistry, dental radiology, dental surgery, and translational/basic nuclear medicine studies.
+- **Open Access:** Yes — fully open access (CC BY-NC 4.0), indexed in DOAJ, PubMed/MEDLINE, Scopus, SCIE
+- **APC (Article Processing Charge):** USD 100 for accepted manuscripts. Exempt: invited articles, Uncover This Tech Term, Emerging Rad Dx, Letter to the Editor.
+- **Language:** English only for manuscripts
+
+---
+
+## Manuscript Types and Limits
+
+Body Text excludes title, abstract, keywords, references, tables, and figure legends.
+
+| Type | Body | Abstract | Figures/Tables | References | Notes |
+|------|------|----------|----------------|------------|-------|
+| Original Article | ≤3000 words | ≤300 words (structured) | ≤7 | unspecified | Structured Introduction / Materials and Methods / Results / Discussion |
+| Brief Research Report | ≤2000 words | ≤300 words (structured) | ≤4 | unspecified | Short paper reporting evaluation of unique techniques, procedures, or small case series; formal statistical analysis may not be needed |
+| Review | ≤5000 words | ≤200 words (unstructured) | ≤10 | unspecified | Narrative comprehensive review; generally invited |
+| Pictorial Essay | ≤2000 words | ≤200 words (unstructured) | ≤20 | unspecified | More illustrative than narrative |
+| Focus | ≤2000 words | ≤200 words (unstructured) | ≤4 | unspecified | Shorter timely review/discussion; generally invited |
+| Recommendation and Guideline | unspecified | ≤200 words (unstructured) | unspecified | unspecified | Authoritative recommendations; must be supported by published studies or expert panels |
+| Editorial | ≤1000 words | No abstract | ≤2 | ≤20 | Generally invited |
+| Uncover This Tech Term | ≤1000 words | No abstract | ≤2 | ≤20 | Title format: "Uncover This Tech Term: xxx" |
+| Emerging Rad Dx | ≤1000 words | No abstract | ≤2 | ≤20 | Explains novel or emerging diseases/conditions |
+| Letter to the Editor | ≤800 words | No abstract | ≤2 | ≤10 | Unstructured without section headings |
+
+**Figure counting rule (PDF p.3 footnote):** A figure may contain multiple parts; **Fig. 1A-C and Fig. 2A-D are counted as two figures, not seven.** Use figure parts or composite figures appropriately to avoid an excessive number of figures.
+
+---
+
+## Abstract Requirements (Original Article and Brief Research Report)
+
+**Structured abstract, ≤300 words:**
+
+```
+Objective: [Study aim]
+Materials and Methods: [Design, population, index test, reference standard, statistics]
+Results: [Key findings with absolute numbers and/or rates, with 95% CIs or P values]
+Conclusion: [Main conclusion — must be consistent with Objective]
+```
+
+Notes:
+- Objective and Conclusion must use the same wording and be consistent with the main text
+- Results must present actual numerical data; not statistical indicators alone
+- Reference citations are not allowed in the abstract
+- Abbreviations should be minimized; if used, define within the abstract at first use
+
+---
+
+## Required Sections (Original Article)
+
+KJR uses IMRAD structure with KJR-specific section naming:
+
+1. **Introduction**
+2. **Materials and Methods** (not "Methods")
+   - Ethics approval and informed consent statement required at the start
+3. **Results**
+4. **Discussion**
+
+---
+
+## Ethics Statement
+
+**Human subjects:**
+> "This study was approved by the Institutional Review Board of [Institution] (approval number: [XXX]), and the requirement for informed consent was [waived/obtained from all participants] because of the [retrospective nature of the study / prospective design]."
+
+**Animal studies:**
+> "All animal experiments were approved by the Institutional Animal Care and Use Committee of [Institution] (approval number: [XXX])."
+
+---
+
+## AI Policy (KJR "Ethical and Responsible Use of Generative AI")
+
+Source: KJR-Instructions-202603.pdf p.2; https://doi.org/10.3348/kjr.2026.0166
+
+- AI tools must not be listed as authors or cited as a primary scholarly source
+- Authors remain fully responsible and accountable for all submitted content and shall be accountable for any ethical or legal breach
+- AI use beyond routine linguistic assistance must be clearly disclosed, with sufficient detail, in the relevant section of the manuscript or in the Acknowledgments
+- When AI itself is the subject of investigation, its use must be explicitly described in the Materials and Methods section
+- Reviewers and editors must safeguard the confidentiality of unpublished manuscripts. Uploading manuscript content or review text to AI services is prohibited unless confidentiality can be reliably assured
+- Reviewers and editors may use AI tools for non-core, assistive purposes under their supervision; core human reviewer functions must not be delegated to AI
+- Reviewers and editors who use AI tools beyond routine linguistic assistance must disclose such use to the journal
+
+---
+
+## Statistical Reporting
+
+- Use 12-point font, double-spaced, 3-cm margins (A4 or letter)
+- Report P values to three decimal places (0.xxx); P < 0.001 reported as "P < 0.001"
+- Do not use more than one decimal place for percentages (x.x%, not x.xx%)
+- Write large numbers with commas separating every three digits (e.g., 123,456,789)
+- 95% confidence intervals required for primary outcomes
+- Results must present absolute numbers and/or rates with appropriate indicators of statistical uncertainty (95% CIs or P values)
+
+---
+
+## Figure Requirements
+
+- **Initial submission:** Embed images in the Word file as JPG/JPEG immediately following relevant figure legends
+- **Revised submission:** Upload images as separate JPG/JPEG (high-quality) or TIF/TIFF files; PNG not accepted
+- **Resolution:** At least 300 dpi; minimum 3 inches, maximum 7 inches in width and height after cropping
+- **Multi-part figures:** Use English letters after numerals (Fig. 1A, 1B, 1C); match figure number with image file name (e.g., Fig_1A.jpg)
+- **Figure number rule:** Composite/multi-part figures are counted by figure number, not by parts (Fig. 1A-C + Fig. 2A-D = 2 figures, not 7)
+- **Anonymization:** Remove all patient names and identifiers; remove all author/institution identifiers
+- **Color:** Online publication is in color; design figures interpretable in print if applicable
+- Written permission required for previously published figures
+
+---
+
+## References
+
+- Vancouver style; numbered consecutively in order of citation in the text
+- **First six authors listed, then "et al."** (≥7 authors). When 6 or fewer, list all authors. (PDF p.4 explicit)
+- Journal names abbreviated per Index Medicus
+- Inclusive page numbers (e.g., 111-114)
+- Unpublished data: cite parenthetically in text, not in reference list
+
+Example (PDF):
+> Park C, Kim JH, Kim PH, Kim SY, Gwon DI, Chu HH, et al. Imaging predictors of survival in patients with single small hepatocellular carcinoma treated with transarterial chemoembolization. *Korean J Radiol* 2021;22:213-224
+
+---
+
+## Common Rejection Reasons
+
+1. **Single-center study with small N** — KJR increasingly prefers multi-center or larger single-center series
+2. **Insufficient clinical relevance** — must explain "so what?" for Korean (or broader Asian/global) clinical practice
+3. **Incomplete ethics documentation** — IRB number required; missing institutional details cause desk rejection
+4. **Poor English language** — KJR provides language editing services but strongly prefers professionally edited manuscripts at submission
+5. **Replication without added value** — replicating a Western study in a Korean cohort is acceptable only if the Korean context adds new knowledge
+
+---
+
+## Positioning
+
+KJR is well-suited for:
+- Korean single-center or multi-center studies
+- Studies on Korean patient populations (gastric cancer, hepatocellular carcinoma, thyroid cancer — prevalent in Korea)
+- AI/radiomics studies with clinical validation
+- Studies that may not reach the impact threshold of higher-tier journals but are methodologically sound
+- Faster time to publication than European or American journals
+
+**Typical timeline:** Minor Revision must be submitted within 30 days of decision; Major Revision within 60 days. Withdrawal not allowed after "under review" status entered.
+
+---
+
+## Author Guidelines URL
+
+https://www.kjronline.org/index.php?body=Instruction
+
+---
+
+## Submission Files Checklist (KJR portal)
+
+- Cover letter
+- Full Title Page (separate Word file, KJR template recommended)
+- Main Document (blinded, single Word file): blinded title page, structured abstract, ~5 keywords, body text, references, tables, figure legends
+- Supplement (separate Word document if applicable)
+- Figures: JPG/JPEG embedded for initial submission; separate JPG/JPEG/TIF/TIFF for revision
+- ICMJE COI Disclosure Form (per author, requested by journal after acceptance)
+- Statement of ethical approval and informed consent at start of Materials and Methods
+
+---
+
+## Formatting Notes
+
+- Manuscript in Microsoft Word format (doc or docx); not PDF
+- 12-point font, double-spaced on A4 or letter paper, ~3-cm margins
+- Do not number pages or lines manually (auto-generated on conversion)
+- SI units throughout (NCRP Report 82, JAMA 1986;255:2329-2339)
+- Abbreviations: define at first use; minimize use
+- Korean author names: use full author name (first, middle if exists, last); not initials
+- Authors should describe sex/gender appropriately; race/ethnicity must be justified
+- Geographic information (city, country) not required for commercial products
+
+---
+
+## Verification
+
+- **Source:** KJR-Instructions-202603.pdf (March 2026 official author instructions)
+- **Date:** 2026-05-21
+- **Notes:** Previous profile spec values were corrected against the canonical PDF: body word limit reduced (4000 → 3000), abstract limit raised (250 → 300), figure cap reduced (8 → 7), and a non-existent "Key Messages" requirement was removed. Missing article types (Brief Research Report, Pictorial Essay, Focus, Recommendation and Guideline, Editorial, Uncover This Tech Term, Emerging Rad Dx) were added. This retrofit aligns with the canonical PDF.

package/skills/write-paper/references/journal_profiles/Korean_Circulation_Journal.md

@@ -0,0 +1,184 @@
+# Journal Profile: Korean Circulation Journal (KCJ)
+
+## Journal Identity
+
+- **Full name**: Korean Circulation Journal
+- **Abbreviation**: Korean Circ J
+- **Publisher**: The Korean Society of Cardiology / The Korean Cardiac Research Foundation
+- **ISSN**: 1738-5520 (print) / 1738-5555 (online)
+- **Frequency**: Monthly
+- **Impact Factor**: ~2.5 (recent JCR; verify at submission)
+- **Open Access**: Open Access, peer-reviewed
+- **Peer review**: Single-blind; methodology review where applicable
+
+## Manuscript Types and Word Limits
+
+| Type | Body Word Limit | Abstract | References | Figures/Tables |
+|------|----------------|----------|------------|----------------|
+| Original Research | 5,000 words | 250 (structured) | not separately capped | ≤8 figures/tables combined |
+| State of the Art Review | 10,000 words | 250 (unstructured or structured) | not separately capped | varies |
+| Perspective | 2,000 words | 150 (unstructured) | varies | ≤4 figures/tables |
+| Image in Cardiovascular Medicine | per portal | none | minimal | ≤2 images |
+| Research Letter | 800 words | none | 10 max | 1 figure/table |
+| Letter to the Editor | 500 words | none | 5 max | minimal |
+
+Word counts exclude abstract, references, tables, and figure legends.
+
+---
+
+## Abstract Requirements
+
+**Structured abstract for Original Research, 250 words maximum, with 4 headings:**
+
+```
+Background and Objectives: [Context, knowledge gap, specific aim]
+Methods: [Design, setting, population, exposures, outcomes, statistical approach]
+Results: [Primary results with effect sizes, 95% CIs, P values; N analyzed]
+Conclusions: [Direct answer to Objectives with clinical implication]
+```
+
+The merged "Background and Objectives" heading is a KCJ-specific stylistic choice (mirrors the Korean society practice). Reviewers check this heading exactly.
+
+---
+
+## Required Journal-Specific Elements
+
+### 1. Central Figure / Graphical Abstract (optional)
+
+Encouraged for Original Research; uploaded as a separate file at submission.
+
+### 2. Article Information
+
+- Author affiliations with department, institution, city, country
+- Corresponding author full contact details (KCJ portal asks for both email and ORCID)
+- Funding statement with grant identifiers
+- Disclosures: per-author ICMJE conflicts
+- Data availability statement
+- Ethical statement (IRB or equivalent + informed consent)
+- Korean and English titles (typeset side-by-side on title page for Korean authors)
+
+---
+
+## Required Sections (Original Research)
+
+1. **Introduction** — 2–3 paragraphs ending with clear objectives
+2. **Methods**
+   - Ethics approval with body name + Korean IRB approval number where applicable
+   - Study design and setting
+   - Participants and eligibility
+   - Variables / definitions
+   - Outcomes (primary, secondary, exploratory clearly distinguished)
+   - Statistical analysis with software and versions
+3. **Results** — STROBE/CONSORT flow; primary outcome before secondary
+4. **Discussion** — Strengths and Limitations sub-paragraphs; conclude with implications, especially for Korean and Asia-Pacific clinical practice
+5. **Conclusions** — brief; avoid overclaiming
+
+---
+
+## Statistical Reporting
+
+- Exact P values to 3 decimal places (P < 0.001 below threshold)
+- 95% CI for all primary effect estimates
+- Effect sizes appropriate to design (HR, OR, mean difference, AUC)
+- Proportional-hazards assumption check (Schoenfeld) when Cox is used
+- Sensitivity analyses for major analytic choices
+- Software and version reported
+
+---
+
+## Figures
+
+- **Maximum 8 figures/tables combined** for Original Research
+- Resolution: 300 DPI minimum
+- Format: TIFF, EPS, PDF, or high-quality PNG
+- Color: encouraged (no fee for online publication)
+- Supplementary material: online-only supplement permitted
+
+---
+
+## Common Rejection Reasons
+
+1. **Insufficient Korean / Asia-Pacific clinical relevance** — manuscripts written purely as Western-style cohort studies without local context lose competitive edge
+2. **Single-center retrospective without external validation** — preferred design is multicenter or population-based
+3. **Methodology gaps** — missing PH check for Cox, missing competing-risks framework when applicable
+4. **Overclaiming on observational data** — wide-CI estimates without exploratory qualifier
+5. **Abstract heading mismatch** — using Background/Methods/Results/Conclusions instead of Background and Objectives/Methods/Results/Conclusions
+6. **Korean–English title mismatch on title page** — Korean authors expected to provide both, side-by-side
+7. **AI policy unclear** — KCJ does not publish a journal-specific AI policy on the Instructions page; authors should default to ICMJE-aligned disclosure and contact the editorial office for clarification
+
+---
+
+## Cover Letter
+
+Must include:
+- Brief statement of novelty and Korean / Asia-Pacific clinical relevance
+- Confirmation manuscript is not under consideration elsewhere
+- Confirmation all authors meet ICMJE criteria
+- Disclosure of related manuscripts (same cohort, same group)
+- Suggested reviewers (3–5; senior PI curates)
+- AI disclosure statement (defensive: include even though the journal does not enforce a specific format)
+
+---
+
+## AI Writing Disclosure Policy
+
+- **Requirement level**: Not explicitly stated on the journal's Instructions for Authors page as of the audit date
+- **Recommended default**: ICMJE-aligned disclosure — declare any AI use beyond routine language assistance in a Methods or Acknowledgments section; AI cannot be listed as author
+- **Editorial office contact**: For author-policy clarification, refer to the journal editorial office via the submission portal contact form
+- **Policy URL**: not separately published; default to ICMJE recommendations
+
+---
+
+## Submission Portal
+
+https://kcj.edmgr.com
+
+---
+
+## Author Guidelines URL
+
+https://e-kcj.org/index.php?body=instructions
+
+---
+
+## Positioning
+
+| Criterion | KCJ | Korean Journal of Internal Medicine (KJIM) | JACC: Asia | JAHA |
+|-----------|-----|--------------------------------------------|------------|------|
+| **Society** | Korean Society of Cardiology | Korean Association of Internal Medicine | ACC (Asia-Pacific focus) | AHA |
+| **Impact Factor** | ~2.5 | ~2.4 | not indexed yet | ~5 |
+| **Open Access** | Open Access | Full OA (CC BY-NC, APC USD 1,000) | Full Gold OA | Full Gold OA |
+| **Geographic stance** | Korean / Asia-Pacific | Korean / East Asian (internal medicine breadth) | Asia-Pacific anchor | Global, NA-centric |
+| **Primary framing** | Cardiology — Korean society flagship | Internal medicine — Korean society flagship | Asia-Pacific cardiology | Cardiovascular broad |
+| **Event-count tolerance** | Moderate; cascade-friendly target | Moderate; cascade-friendly target | Moderate (Asia-Pacific data privileged) | Moderate–high |
+| **Abstract first heading** | Background and Objectives | Background/Aims | Background | Background |
+| **Word cap (Original)** | 5,000 | varies (Korean-style) | 5,000 | none stated |
+| **AI policy** | Not on Instructions page | Acknowledgments verbatim (KJIM-specific) | ACC/Elsevier | AHA family-wide |
+
+**Choose KCJ when:**
+- Korean cardiovascular cohort paper needs a guaranteed publication path and KSC community visibility
+- Cascade safety-net target after rejection from higher-IF cardiology journals
+- Korean clinical-practice relevance is the dominant framing
+- Authors prefer the Korean Society of Cardiology editorial relationship
+
+**Choose KJIM instead when:**
+- The manuscript spans internal medicine subspecialties beyond pure cardiology
+- KAIM ecosystem visibility matters more than KSC
+
+**Choose JACC: Asia instead when:**
+- Asia-Pacific regional contribution is the dominant framing (broader than Korea-specific)
+- ACC ecosystem visibility and Full Gold OA matter
+
+**Choose JAHA instead when:**
+- Cross-modality cardiovascular–cerebrovascular framing
+- Higher IF and AHA family alignment matter
+- Negative or hypothesis-generating findings benefit from JAHA's tolerance
+
+---
+
+## Verification
+
+- **Source (compact harvest):** local private profile (2026-05-20 fetch from https://e-kcj.org/index.php?body=instructions)
+- **Source (detail authored):** based on harvested compact + KSC standard practice + ICMJE-aligned defensive defaults for AI policy
+- **Date (promoted to public):** 2026-05-21
+- **Notes:** AI policy is not published on the Instructions page; authors should default to ICMJE disclosure. Verify IF and APC directly on the journal site at submission.